RX Herculink Elite Renal Stent System

COMPANY Abbott

PHONE (800) 227-9902

WEB www.abbottvascular.com

KEY FEATURES

  • Low restenosis rate
  • Controlled hypertension
  • Cobalt chromium technology
  • Designed for deliverability
  • 6-F guide catheter compatible for all sizes

RX Herculink Elite Renal Stent System (Abbott, Santa Clara, CA) is the first stent using cobalt chromium technology to gain a renal indication in the United States. The cobalt chromium alloy allows for thin stent struts, providing increased flexibility while maintaining strength to support the vessel and visibility during a stent implantation procedure for accurate placement. This approval is supported by the HERCULES study, which demonstrated that RX Herculink Elite is safe and effective in patients with renal artery stenosis and uncontrolled hypertension.

“One striking result of the HERCULES study was the reduction in blood pressure we saw with RX Herculink Elite in patients with uncontrolled hypertension-those who are not adequately managed with multiple blood pressure medications,” said Michael R. Jaff, DO, medical director of the Vascular Center and VasCore, the Vascular Ultrasound Core Laboratory that participated in the HERCULES trial, both at the Massachusetts General Hospital in Boston. “This result supports renal stenting as an important treatment option, as elevations in blood pressure can increase heart disease and stroke risk in patients with renal artery stenosis.”


K-Pack Surshield Hypodermic Needle

COMPANY Terumo Medical Corporation

PHONE (410) 398-8500

WEB www.terumomedical.com

KEY FEATURES

  • Low restenosis rate
  • Individually packaged and sterile
  • Container is tamper-evident and color-coded
  • Designed for deliverability

Terumo Medical Corporation (Somerset, NJ) recently received 510(k) clearance from the US Food and Drug Administration to market the new K-Pack Surshield hypodermic needle featuring integrated, passive sharps protection for use with prefilled syringes for intramuscular and subcutaneous pharmaceutical applications. The K-Pack Surshield comes individually packaged and sterile in a rigid container with a tamper-evident and colorcoded label. US Customers will have access to the K-Pack Surshield with Terumo's high-quality 25-g X 0.625-inch or 27-g X 0.5-inch needles designed for minimal patient trauma.

“Terumo's innovative K-Pack Surshield offers exceptional performance and safety for the health care professional,” said Juichi (Jim) Takeuchi, President and CEO, of Terumo Medical Corporation.